Our Partners in Latin America
Biopas, a Swixx Biopharma company, is one of the leading pharmaceutical commercialization platforms in Latin America, with established presence in therapy areas of CNS, immunology, dermatology, oncology, gastroenterology, and orphan drugs. Operating through fully owned subsidiaries and a workforce of over 350 employees, Biopas provides integrated sales, marketing, medical, and support services, adhering to the highest international standards. The company ensures access to innovative therapeutic solutions from its partners, covering unmet medical needs of patients in niche indications.
With more than 20 years of experience and a history of successful collaborations with major industry partners, Biopas offers a turnkey solution for launching and growing pharmaceutical products in the region.
The operations in Latin America are led by an experienced management team:
Executive and founder of Biopas Laboratories with 35+ years leading pharma operations at Schering-Plough, Grupo Farma, and Hoechst Roussel, focused on regional leadership, international expansion, and strategic growth.
Co-founder of Biopas Laboratories with 25+ years in marketing and commercial roles at Abbott, Grupo Farma, NovaFarma, and Biogen, focused on cardiology, antivirals, and CNS portfolio leadership.
Marketing leader with 25+ years at Pfizer, Schering-Plough, and Grupo Farma, driving regional strategy, product launches, and growth of respiratory and OTC portfolios.
Neurologist with 25+ years at Abbott and AbbVie, leading medical, immunology, market access, and commercial functions across Latin America; experienced in cross-functional leadership and evidence-based strategy.
Finance leader with 15+ years at Sanofi and Saint-Gobain, specializing in financial planning, internal audit, project evaluation, and supply chain performance improvement across Latin America.
Human resources executive with 15+ years at EPS Famisanar and Codere, expert in talent management, organizational culture, change leadership, and building high-performing, people-centric organizations.
Driving strategic brand growth and market leadership across Latin America through the development and execution of integrated marketing plans that combine scientific excellence, market access, medical engagement, and commercial performance.
Medical Affairs shapes scientific leadership across LATAM, championing evidence-based communication and transforming clinical innovation into better patient outcomes through education, data generation (in alignment with our partners), and trusted partnerships with healthcare professionals.
Market Access ensures sustainable access to innovation across LATAM by aligning clinical value, economic evidence, and policy engagement. The team develops successful negotiation models with payers, institutions, and governments to enable patient access while supporting long-term business growth.
Patient Support Programs, managed by specialized third parties for selected Biopas’ products, strengthening patient access and adherence across LATAM. All Biopas’ Patient Support Programs follow rigorous ethics and compliance standards and udergo comprehensive independent audits.
Biopas ensures an end-to-end controlled environment through a code of conduct policies and procedures including interactions with HCPs, public and patient organizations, anti-bribery and anti-corruption, conflicts of interest, antitrust and fair competition, and product quality and etc.; it delivers onboarding and annual training, maintains an Ethics Line for employees and third parties with confidentiality and non-retaliation, applies risk based supplier due diligence, and runs continuous internal and external monitoring with frequent partner audits. Biopas adheres to Swixx Group compliance standards — learn more here — and holds ISO 37001:2016 Anti Bribery Management System certification.
Biopas safeguards the product lifecycle across LATAM, maintaining 600+ active Marketing Authorizations and upholding regulatory integrity, IP protection, and product quality to preserve authority trust and business continuity. Biopas operates QC labs in Brazil and Argentina and aligns its Quality Management System with EMA/FDA standards.
Delivering reliable, compliant distribution across LATAM through certified 3PL and best-in-class supplier partnerships, safeguarding cold-chain integrity and secondary packaging, and enforcing rigorous quality, traceability, and continuous audits.
Pharmacovigilance service in Latin America is the regional implementation of pharmacovigilance systems that monitor the safety of medicines throughout their life cycle. These services are responsible for collecting, analyzing, and acting upon reports of adverse drug reactions (ADRs), medication errors, and other safety concerns, in alignment with international standards set by the World Health Organization (WHO) and regional health authorities such as the Pan American Health Organization (PAHO).
Biopas, a Swixx Biopharma company, is committed to creating solid, faithful, long-term relationships with its partners to launch and commercialize new products in the Latin American region.
If you would like to partner with us, please get in touch with our Business Development Team BD.LATAM@swixxbiopharma.com
Swixx Biopharma AG
Neuhofstrasse 5A
CH-6340 Baar
Switzerland
Tel. +41 41 5523 440
info@swixxbiopharma.com
Hybernská 5, 11000 Praha 1
Czech Republic
Tel. +420 242 434 242
info@swixxbiopharma.com
